OWC Pharmaceutical Research Corp (OWCP)

[Triple9]

I can see $OWCP going to $20 rather quickly.

With Jeffrey Friedland attending so many financial conferences in Q1, OWCP's strategy is easy to guess: uplist to NASDAQ asap and attract institutional investors.

I'm new to Pharma stocks, but was very pleasantly surprised to see, as per Stern business school, PE ratios of "Drug (Bio)" companies are a staggering 321.61 whereas "Drug (Pharma)" has a lofty PE of 182.25.

http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/pedata.html

If you do some simple math with OWCP having only around 179 Million shares outstanding and project a very modest amount of revenue coming from the Q2 psoriasis cream, you have a extremely high and realistic share price in 2017.

Go OWCP!!!